Drug Shortage Report for STRENSIQ

Last updated on 2021-10-04 History
Report ID 126788
Drug Identification Number 02444615
Brand name STRENSIQ
Common or Proper name ASFOTASE ALFA
Company Name ALEXION PHARMA GMBH
Market Status MARKETED
Active Ingredient(s) ASFOTASE ALFA
Strength(s) 40MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 2ML, 3ML
ATC code A16AB
ATC description OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-04-01
Actual start date
Estimated end date
Actual end date 2021-09-14
Shortage status Resolved
Updated date 2021-10-04
Company comments 18mg/0.45mL (40mg/mL) presentation
Health Canada comments
Tier 3 Status No
Contact Address GIESSHUBELSTRASSE 30
ZURICH, ZURICH
SWITZERLAND 8045
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2021-10-04 French Compare
v14 2021-10-04 English Compare
v13 2021-09-13 English Compare
v12 2021-09-13 French Compare
v11 2021-09-13 English Compare
v10 2021-04-02 English Compare
v9 2020-12-03 French Compare
v8 2020-12-03 English Compare
v7 2020-12-02 English Compare
v6 2020-10-21 French Compare
v5 2020-10-21 English Compare
v4 2020-10-21 French Compare
v3 2020-10-21 English Compare
v2 2020-10-21 French Compare
v1 2020-10-21 English Compare

Showing 1 to 15 of 15